Petco Health and Wellness Company (WOOF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for July 24, 2025, to be held virtually, with stockholders able to vote online, by phone, or by mail.
Key proposals include electing three Class II directors, a non-binding advisory vote on executive compensation, and ratification of the external auditor.
The board recommends voting in favor of all proposals and emphasizes expanded stockholder access and engagement through the virtual format.
Voting matters and shareholder proposals
Proposal 1: Election of three Class II directors for three-year terms.
Proposal 2: Advisory vote to approve named executive officer compensation.
Proposal 3: Ratification of Ernst & Young LLP as independent auditor for fiscal year ending January 31, 2026.
Board unanimously recommends voting “FOR” all proposals.
Board of directors and corporate governance
Board consists of 11 directors (reducing to 10 after the meeting), with five independent members.
Board is divided into three classes with staggered three-year terms.
Controlled company status exempts from some Nasdaq requirements, but audit committee remains fully independent.
Principal Stockholder holds about 66% voting power for director elections and has rights to nominate directors and committee members.
Board leadership is separated between Executive Chairman and CEO.
Latest events from Petco Health and Wellness Company
- Profitability and cash flow surged in 2025, with leverage ratio reduced to 3.0x.WOOF
Q4 202611 Mar 2026 - Q2 revenue fell, losses widened, and cost discipline intensified amid macroeconomic headwinds.WOOF
Q2 202521 Jan 2026 - Q3 revenue grew 1.2%, margin improved, and positive free cash flow is on track.WOOF
Q3 202511 Jan 2026 - Q4 2024 comp sales rose and free cash flow turned positive, but revenue and EBITDA declined.WOOF
Q4 202526 Dec 2025 - Profitability and cash flow improved in Q3 2025, despite a 3.1% sales decline.WOOF
Q3 20265 Dec 2025 - Joel D. Anderson named CEO effective July 29, 2024, with expanded Board and updated leadership.WOOF
Proxy Filing1 Dec 2025 - Virtual meeting to vote on directors, executive pay, and auditor ratification July 24, 2025.WOOF
Proxy Filing1 Dec 2025 - Q2 2025 saw higher margins and earnings despite lower sales, with guidance raised.WOOF
Q2 202623 Nov 2025 - Adjusted EBITDA rose to $89.4M as margins improved despite lower sales and reaffirmed guidance.WOOF
Q1 202612 Nov 2025